Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Development (Cambridge, England)
|
January 1, 1997
BMP-7 influences pattern and growth of the developing hindbrain of mouse embryos
R Arkell, R S Beddington
Australian Journal of General Practice
|
June 1, 2021
Medical cannabis and driving
Thomas R Arkell, Danielle McCartney, Iain S McGregor
Neuroscience and Biobehavioral Reviews
|
January 26, 2021
Determining the magnitude and duration of acute Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review
Danielle McCartney, Thomas R Arkell, Christopher Irwin, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 9, 2024
A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance
Brooke Manning, Thomas R Arkell, Amie C Hayley, et al.
Development (Cambridge, England)
|
April 1, 1994
Expression of inhibin subunits and follistatin during postimplantation mouse development: decidual expression of activin and expression of follistatin in primitive streak, somites and hindbrain
R M Albano, R Arkell, R S Beddington, et al.
CNS Drugs
|
November 9, 2023
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
Thomas R Arkell, Brooke Manning, Luke A Downey, et al.
Addiction Biology
|
March 1, 2022
Acute effects of amphetamine and related psychostimulants on impulsivity: a systematic review of clinical trials
Thomas R Arkell, Kristina Bradshaw, Luke A Downey, et al.
JAMA Network Open
|
May 9, 2023
Assessment of Medical Cannabis and Health-Related Quality of Life
Thomas R Arkell, Luke A Downey, Amie C Hayley, et al.
Neuroscience and Biobehavioral Reviews
|
November 12, 2021
Are blood and oral fluid Δ<sup>9</sup>-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis
Danielle McCartney, Thomas R Arkell, Christopher Irwin, et al.
Traffic Injury Prevention
|
February 5, 2021
The failings of <i>per se</i> limits to detect cannabis-induced driving impairment: Results from a simulated driving study
Thomas R Arkell, Tory R Spindle, Richard C Kevin, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Development (Cambridge, England)
|
January 1, 1997
BMP-7 influences pattern and growth of the developing hindbrain of mouse embryos
R Arkell, R S Beddington
Australian Journal of General Practice
|
June 1, 2021
Medical cannabis and driving
Thomas R Arkell, Danielle McCartney, Iain S McGregor
Neuroscience and Biobehavioral Reviews
|
January 26, 2021
Determining the magnitude and duration of acute Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review
Danielle McCartney, Thomas R Arkell, Christopher Irwin, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 9, 2024
A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance
Brooke Manning, Thomas R Arkell, Amie C Hayley, et al.
Development (Cambridge, England)
|
April 1, 1994
Expression of inhibin subunits and follistatin during postimplantation mouse development: decidual expression of activin and expression of follistatin in primitive streak, somites and hindbrain
R M Albano, R Arkell, R S Beddington, et al.
CNS Drugs
|
November 9, 2023
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
Thomas R Arkell, Brooke Manning, Luke A Downey, et al.
Addiction Biology
|
March 1, 2022
Acute effects of amphetamine and related psychostimulants on impulsivity: a systematic review of clinical trials
Thomas R Arkell, Kristina Bradshaw, Luke A Downey, et al.
JAMA Network Open
|
May 9, 2023
Assessment of Medical Cannabis and Health-Related Quality of Life
Thomas R Arkell, Luke A Downey, Amie C Hayley, et al.
Neuroscience and Biobehavioral Reviews
|
November 12, 2021
Are blood and oral fluid Δ<sup>9</sup>-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis
Danielle McCartney, Thomas R Arkell, Christopher Irwin, et al.
Traffic Injury Prevention
|
February 5, 2021
The failings of <i>per se</i> limits to detect cannabis-induced driving impairment: Results from a simulated driving study
Thomas R Arkell, Tory R Spindle, Richard C Kevin, et al.
Page
of 4